Endonovo Therapeutics (ENDV) Stock Price, News & Analysis

Company Overview

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.

Key Stats

• Today's Range: $0.0002 to $0.0003
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0019
• Volume: 8,512 shs
• Average Volume: 22.11 million shs
• Market Capitalization: $241.32 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ENDV Stock Analysis - Frequently Asked Questions

How have ENDV shares performed this year?

Endonovo Therapeutics' stock was trading at $0.0004 at the start of the year. Since then, ENDV stock has decreased by 50.0% and is now trading at $0.0002.
View the best growth stocks for 2025 here.

How do I buy shares of Endonovo Therapeutics?

Shares of ENDV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Endonovo Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Endonovo Therapeutics investors own include Chesapeake Energy (CHKAQ), Novavax (NVAX), Energous (WATT), Advanced Micro Devices (AMD), BioLineRx (BLRX), Citigroup (C) and Ekso Bionics (EKSO).

Company Calendar

• Today: 6/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:ENDV
• CIK: 1528172
• Web: www.endonovo.com
• Phone: (800) 489-4774
• Fax: 818-230-9899
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $10 thousand
• Price / Sales: 24.13
• Cash Flow: $0.02 per share
• Price / Cash Flow: 0.01
• Book Value: ($0.08) per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 1,206,610,000
• Free Float: 1,138,923,000
• Market Cap: $241.32 thousand
• Optionable: Not Optionable
• Beta: -1.83